Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ERα antagonists(Estrogen receptor alpha antagonists), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC33H34FN3O5SSe |
InChIKeyOVNVQSFVXDRGGF-UHFFFAOYSA-N |
CAS Registry2922929-62-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | CN | 16 Aug 2023 |